Contact
searchSearch
HMP Global

Parkinson Disease Excellence Forum

Parkinson Disease
Excellence Forum
Leaders in the field sharing authoritative insights and institutional best practices.

Podcasts
DNL201 and LRRK2 Inhibition in Parkinson Disease: Phase 1b Trial Results
01/04/2021
In this podcast, Joohi Jimenez-Shahed, MD, discusses the findings of the study, “Safety, Tolerability, and Pharmacodynamic Profile of DNL201 at dose levels demonstrating LRRK2 inhibition in Parkinson's Disease Patients with and without LRRK2...
In this podcast, Joohi Jimenez-Shahed, MD, discusses the findings of the study, “Safety, Tolerability, and Pharmacodynamic Profile of DNL201 at dose levels demonstrating LRRK2 inhibition in Parkinson's Disease Patients with and without LRRK2...
In this podcast, Joohi...
01/04/2021
Neurology
Q&As
Parkinson Disease: Noninvasive Retinal Imaging Parameters May Be Potential Biomarkers
12/30/2020
Researchers answered our questions about their recent study, which suggested that noninvasive retinal imaging parameters should be investigated further as potential biomarkers of Parkinson disease.
Researchers answered our questions about their recent study, which suggested that noninvasive retinal imaging parameters should be investigated further as potential biomarkers of Parkinson disease.
Researchers answered our...
12/30/2020
Neurology
Q&As
Advances in Clinical Genetic Testing for Parkinson Disease
12/02/2020
Neurology Learning Network spoke with Rachel Saunders-Pullman, MD, MPH; Tanya Simuni, MD; and Tara Hastings, MA, who recently discussed clinical genetic testing for Parkinson disease at the American Neurological Association’s 145th Annual...
Neurology Learning Network spoke with Rachel Saunders-Pullman, MD, MPH; Tanya Simuni, MD; and Tara Hastings, MA, who recently discussed clinical genetic testing for Parkinson disease at the American Neurological Association’s 145th Annual...
Neurology Learning Network spoke...
12/02/2020
Neurology
Podcasts
Alastair Noyce, MD, on Access to Parkinson Medication During COVID-19
11/25/2020
Alastair Noyce, MD, discusses his recent study, which found that patients with Parkinson disease have likely had less access to medication during the COVID-19 pandemic, which in turn may impact patients' symptomatic control.
Alastair Noyce, MD, discusses his recent study, which found that patients with Parkinson disease have likely had less access to medication during the COVID-19 pandemic, which in turn may impact patients' symptomatic control.
Alastair Noyce, MD, discusses...
11/25/2020
Neurology
Q&As
α-Synuclein Active Immunotherapeutic Drug Appears Safe and Effective, and Generates Immune Response in Parkinson Disease
11/20/2020
Early findings presented at the International Parkinson and Movement Disorders 2020 Virtual Congress indicate that an α-synuclein active immunotherapeutic drug appears to be safe and well-tolerated, and generated a substantial humoral immune...
Early findings presented at the International Parkinson and Movement Disorders 2020 Virtual Congress indicate that an α-synuclein active immunotherapeutic drug appears to be safe and well-tolerated, and generated a substantial humoral immune...
Early findings presented at the...
11/20/2020
Neurology
Podcasts
Bhavya R. Shah, MD, on Advanced MRI Techniques for Transcranial HIFU Targeting
10/14/2020
In this podcast, Dr Shah discusses the imaging and treatment modalities he and his colleagues reviewed in their recent article, "Advanced MRI techniques for transcranial high intensity focused ultrasound targeting," which was published in the...
In this podcast, Dr Shah discusses the imaging and treatment modalities he and his colleagues reviewed in their recent article, "Advanced MRI techniques for transcranial high intensity focused ultrasound targeting," which was published in the...
In this podcast, Dr Shah...
10/14/2020
Neurology
Published in Partnership
5 Questions on α-Synuclein Reactive T Cells and Preclinical Parkinson Disease
06/22/2020
New findings suggest that α-synuclein reactive T cells may be present years before the diagnosis of motor Parkinson disease. Neurology Consultant discussed these findings further with study author David Sulzer, PhD, from Columbia University...
New findings suggest that α-synuclein reactive T cells may be present years before the diagnosis of motor Parkinson disease. Neurology Consultant discussed these findings further with study author David Sulzer, PhD, from Columbia University...
New findings suggest that...
06/22/2020
Neurology
Q&As
4 Questions About Advanced MRI Techniques for Transcranial HIFU Targeting
04/28/2020
A new review indicates that newer, advanced MRI technology can serve as a “promising alternative” to subjective landmark-based methods for transcranial high intensity focused ultrasound targeting. Neurology Consultant discussed the...
A new review indicates that newer, advanced MRI technology can serve as a “promising alternative” to subjective landmark-based methods for transcranial high intensity focused ultrasound targeting. Neurology Consultant discussed the...
A new review indicates that...
04/28/2020
Neurology
Videos
Examining Gender Disparities in PD Research and Treatment
08/21/2019
Allison Willis, MD, discusses efforts to address the "female paradox of Parkinson disease."
Allison Willis, MD, discusses efforts to address the "female paradox of Parkinson disease."
Allison Willis, MD, discusses...
08/21/2019
Neurology
Q&As
Q&A: A Potential Blood Test for Parkinson Disease
04/25/2019
Gal Bitan, PhD, from UCLA, answers our questions about his research on a potential blood test for diagnosing PD, which can also distinguish between PD and multiple system atrophy.
Gal Bitan, PhD, from UCLA, answers our questions about his research on a potential blood test for diagnosing PD, which can also distinguish between PD and multiple system atrophy.
Gal Bitan, PhD, from UCLA,...
04/25/2019
Neurology

Migraine CME Series

News

An orange prescription container with generic pills spilling out in front of it
News
Antidepressant Use Not Linked to Worse Traumatic Brain Injury Outcomes
02/03/2026
Brionna Mendoza
A large nationwide cohort study found no evidence that preinjury antidepressant use increases short-term mortality, need for emergency brain surgery, or length of hospitalization following TBI.
A large nationwide cohort study found no evidence that preinjury antidepressant use increases short-term mortality, need for emergency brain surgery, or length of hospitalization following TBI.
A large nationwide cohort study...
02/03/2026
Psych Congress Network
a mother and daughter sit at a table
News
Fremanezumab Reduces Migraine Days in Pediatric Episodic Migraine
01/30/2026
Maria Mantas
In a recent randomized, placebo-controlled trial, researchers found that fremanezumab significantly reduced monthly migraine days compared with placebo in children and adolescents with episodic migraine. 
In a recent randomized, placebo-controlled trial, researchers found that fremanezumab significantly reduced monthly migraine days compared with placebo in children and adolescents with episodic migraine. 
In a recent randomized,...
01/30/2026
Neurology
fda building sign
News
FDA Approves Copper Histidinate Treatment for Pediatric Menkes Disease
01/19/2026
Brionna Mendoza
The US Food and Drug Administration (FDA) approved a copper histidinate (Zycubo) injection as the first treatment for Menkes disease in pediatric patients.
The US Food and Drug Administration (FDA) approved a copper histidinate (Zycubo) injection as the first treatment for Menkes disease in pediatric patients.
The US Food and Drug...
01/19/2026
Neurology
brain scans
News
Endovascular Thrombectomy Shows Durable 3-Year Benefit in Basilar Artery Occlusion
01/06/2026
Maria Mantas
Endovascular thrombectomy (EVT) provides durable functional and survival benefits for patients with acute basilar artery occlusion, according to long-term follow-up data from a randomized clinical trial. 
Endovascular thrombectomy (EVT) provides durable functional and survival benefits for patients with acute basilar artery occlusion, according to long-term follow-up data from a randomized clinical trial. 
Endovascular thrombectomy (EVT)...
01/06/2026
Neurology
A doctor prescribing medication for a pregnant woman
News
Antiseizure Medication Dose Adjustments During Pregnancy: Findings from the MONEAD Study
01/06/2026
Sarah Fleming
A new analysis from the US-based Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD) study, published in Neurology, examines how antiseizure medications (ASMs) were adjusted during pregnancy and early postpartum...
A new analysis from the US-based Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD) study, published in Neurology, examines how antiseizure medications (ASMs) were adjusted during pregnancy and early postpartum...
A new analysis from the US-based...
01/06/2026
Neurology
A doctor fills out a form while meeting with a patient
News
AAN Issues Evidence-Based Guideline for Management of Functional Seizures
12/18/2025
Sarah Fleming
A new clinical practice guideline from the American Academy of Neurology (AAN), published in Neurology, provides comprehensive recommendations for diagnosing and managing functional seizures.
A new clinical practice guideline from the American Academy of Neurology (AAN), published in Neurology, provides comprehensive recommendations for diagnosing and managing functional seizures.
A new clinical practice...
12/18/2025
Neurology
A doctor reviews test results with an older female patient
News
Late-Window IV Thrombolysis Before Transfer May Improve Stroke Outcomes
12/17/2025
Sarah Fleming
A multicenter study suggests that extended-window IV thrombolysis before thrombectomy transfer may enhance outcomes and recanalization in AIS-LVO without increasing hemorrhagic risk.
A multicenter study suggests that extended-window IV thrombolysis before thrombectomy transfer may enhance outcomes and recanalization in AIS-LVO without increasing hemorrhagic risk.
A multicenter study suggests...
12/17/2025
Neurology
News
Fine Particulate Air Pollution Linked to Greater Alzheimer Neuropathology, Study Finds
12/16/2025
Grace Taylor, MS, MA
Research published in JAMA Neurology links higher exposure to fine particulate air pollution (PM2.5) with more severe Alzheimer-related brain changes and faster cognitive decline in older adults.
Research published in JAMA Neurology links higher exposure to fine particulate air pollution (PM2.5) with more severe Alzheimer-related brain changes and faster cognitive decline in older adults.
Research published in JAMA...
12/16/2025
Annals of Long-Term Care
a man lies in bed sleeping while wearing a CPAP machine
News
Untreated Sleep Apnea Nearly Doubles Parkinson Disease Risk
12/09/2025
Brionna Mendoza
Obstructive sleep apnea (OSA) appears to nearly double the risk for later development of Parkinson disease (PD), but early continuous positive airway pressure (CPAP) treatment may attenuate that risk by 30%.
Obstructive sleep apnea (OSA) appears to nearly double the risk for later development of Parkinson disease (PD), but early continuous positive airway pressure (CPAP) treatment may attenuate that risk by 30%.
Obstructive sleep apnea (OSA)...
12/09/2025
Neurology
Two doctors review research data on a computer in a lab
News
Deramiocel Meets Key Endpoints in Phase 3 HOPE-3 Duchenne Trial
12/05/2025
Brionna Mendoza
Deramiocel, an investigational cell therapy for the treatment of cardiomyopathy associated with Duchenne muscular dystrophy (DMD), met its primary and secondary endpoints in the phase 3 HOPE-3 trial, according to Capricor Therapeutics.
Deramiocel, an investigational cell therapy for the treatment of cardiomyopathy associated with Duchenne muscular dystrophy (DMD), met its primary and secondary endpoints in the phase 3 HOPE-3 trial, according to Capricor Therapeutics.
Deramiocel, an investigational...
12/05/2025
Neurology

Alzheimer's Disease CME Series

Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/17/2020
Neurology

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use